1 row is stored for this page
| Field | Field type | Value |
|---|
| generic | String | Moxifloxacin |
| brand | String | Avelox (oral/IV brand discontinued US); Vigamox, Moxeza (ophthalmic) |
| structure | File | |
| classes | List of String, delimiter: , | [[:Category:Fluoroquinolones|Fluoroquinolone antibiotic]] • [[:Category:Antibacterials|Antibacterial]] |
| mechanism | String | '"`UNIQ--vote-00000D7A-QINU`"' Substantial QT-interval prolongation — the most QT-prolonging fluoroquinolone — limits use in patients on other QT-prolonging agents or with electrolyte abnormalities'"`UNIQ--ref-00000D7B-QINU`"'. |
| uses | String | '"`UNIQ--vote-00000D7C-QINU`"', '"`UNIQ--vote-00000D7D-QINU`"', '"`UNIQ--vote-00000D7E-QINU`"', '"`UNIQ--vote-00000D7F-QINU`"', '"`UNIQ--vote-00000D80-QINU`"', '"`UNIQ--vote-00000D81-QINU`"' |
| starting_dose | String | 400 mg PO/IV once daily |
| preparations | String | 400 mg tablets; 400 mg/250 mL IV; 0.5% ophthalmic solution |
| fda_max | String | 400 mg/d |
| pill_id | Text | |
| routes | List of String, delimiter: , | Oral • IV • topical ophthalmic |
| onset | String | Hours |
| duration | String | 24 hours |
| halflife | String | ~12 hours'"`UNIQ--ref-00000D82-QINU`"' |
| bioavailability | String | ~90% (oral; not affected by food but reduced by divalent cations)'"`UNIQ--ref-00000D83-QINU`"' |
| pregnancy | String | '''Avoid in pregnancy where alternatives exist''' (animal cartilage toxicity).<sup class="pcp-cn" title="This claim needs a citation.">[[[Pharmacopedia:Citation needed|citation needed]]]</sup> |
| legal | String | [[USLegal:Prescription only|Rx-only]] in US. Carries the same fluoroquinolone-class '''Boxed Warnings''' as ciprofloxacin/levofloxacin'"`UNIQ--ref-00000D84-QINU`"' |
